Danavish Clopidogrel 75mg Tablet
24,00 ₹
Аналоги Danavish Clopidogrel 75mg Tablet
Знайдіть доступніші аналоги та дженерики для Danavish Clopidogrel 75mg Tablet.
Активний інгредієнт: Clopidogrel
Опис товару
About Danavish Clopidogrel
Danavish Clopidogrel is a medication containing the active ingredient Clopidogrel, classified as Antiplatelet medication. Clopidogrel, sold under the brand name Plavix among others, is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Clopidogrel tablets are a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome – For patients with non–ST-segment.
- Use only as directed on the product label or by a healthcare professional.
- Follow the authorised product information for dosing and duration of use.
Active Ingredient & Action
Clopidogrel, the active ingredient in Danavish Clopidogrel, belongs to the Antiplatelet medication class. 1 INDICATIONS AND USAGE Clopidogrel tablets are a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), clopidogrel tablets have been shown to reduce the rate of myocardial infarction. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Danavish Clopidogrel. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Danavish Clopidogrel for extended periods without medical advice.
Знайти в аптеках
Порівняйте місцеві ціни та відстань для Danavish Clopidogrel 75mg Tablet.
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.